Planning & Evaluation

MCCC采用内部和外部审查机制，为以下公司做出的战略决策提供信息 并提供必要的反馈，以便对这些决定的有效性进行持续评估。 MCCC在这方面的努力是广泛和包容的，采用了各种战略。 制定了总体战略规划、审查已制定和正在制定的方案的程序； 以及对已建立和正在开发的共享设施进行审查。他们以明确的愿景为指导， 由中心主任和高级领导开发并由癌症中心协调的中心 行政部门。这一愿景与NCI中心计划的目标和NCI的使命是一致的 并建立在对当前和未来癌症科学机会的仔细评估的基础上 研究以及如何利用Mayo Clinic的独特能力来定义特定领域 力量。这一总体愿景被用来帮助评估 项目和共享设施--甚至是个别中心成员。这些努力因此告知SITE和 投资组合和方案稳定与增长、一体化、投资的全中心优先事项 基础设施--特别是共享资源、征聘、保健差距和设施以及使用 可自由支配的资源，包括CCSG发展基金。 MCCC利用外部专家和管理人员在以下方面提供洞察和评估专业知识 癌症中心正在进行的审查。MCCC计划和评估的支柱是投入 由外部咨询委员会(EAC)提供。这一群体在Dr。 迪亚西奥在2006年秋天被招募，在指导MCCC方面一直是不可或缺的。

The MCCC employs both internal and external review mechanisms to inform the strategic decisions made by the Center and to provide feedback necessary for ongoing evaluation of the effectiveness of those decisions. The MCCC's efforts in this regard are broad and encompassing, employing a variety of strategies. Processes are in place for overall strategic planning, review of the established and developing programs, and review of the established and developing shared facilities. They are guided by a clear vision for the Center developed by the Center Director and Senior Leadership and facilitated by Cancer Center Administration. The vision is consistent with the goals of the NCI Centers Program and the mission of the Mayo Clinic, and built upon a careful assessment of the current and future scientific opportunities in cancer research and how the unique capabilities of Mayo Clinic can be leveraged to define areas of particular strength. This overall vision is used to help evaluate recommendations brought forward by leaders of programs and shared facilities - and even individual Center members. These efforts thus inform site and center-wide priorities for portfolio and programmatic stabilization and growth, integration, investment in infrastructure - notably shared resources, recruitment, health disparities and facilities, and use of discretionary resources including CCSG Developmental Funds. The MCCC utilizes expert outside scientists and administrators to provide insight and evaluative expertise in the ongoing review of the Cancer Center. The mainstay of the MCCC's planning and evaluation is the input provided by the External Advisory Committee (EAC). This group, reconstituted and expanded following Dr. Diasio's recruitment in the fall of 2006, has been indispensable in guiding the MCCC.